Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00608855 · ClinicalTrials.gov registry record · NA

Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT00608855: Completed NA study, sponsored by Mayo Clinic.

NCT00608855 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00608855, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

RATIONALE: Percutaneous cryoablation may help relieve pain caused by bone metastases. PURPOSE: This clinical trial is studying the side effects and how well percutaneous cryoablation works in treating patients with painful bone metastases.

Interventions

  • OTHER questionnaire administration
  • PROCEDURE quality-of-life assessment
  • PROCEDURE pain therapy
  • PROCEDURE cryosurgery

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2003-11
Est. Completion 2013-02
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT00608855 record still lists

NCT00608855 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 4 interventions - of which questionnaire administration is the first listed.

NCT00608855 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00608855 about?

NCT00608855 is a clinical study titled "Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases". RATIONALE: Percutaneous cryoablation may help relieve pain caused by bone metastases. PURPOSE: This clinical trial is studying the side effects and how well percutaneous cryoablation works in treating patients with painful bone metastases.

What is the current status of trial NCT00608855?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2003-11. Estimated completion is 2013-02.

What interventions are being tested in trial NCT00608855?

The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), pain therapy (PROCEDURE), cryosurgery (PROCEDURE).

Who is sponsoring clinical trial NCT00608855?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00608855's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00608855, the US trial registry maintained by the National Library of Medicine. NCT00608855 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.